Stay updated on Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.

Latest updates to the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 updated from v3.4.0; this appears to be a backend/UI metadata update with no changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a 'Show glossary' option and updated versioning/QC labels to 'Revision: v3.4.0' while removing older QC labels and 'No FEAR Act data' references from the previous version.SummaryDifference0.2%

- Check34 days agoChange Detected- The study record status changed from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted for this trial.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section listing Leicestershire as the study site. The page revision was updated to v3.3.3, and the HHS Vulnerability Disclosure and Leicestershire Locations elements were removed.SummaryDifference0.2%

Stay in the know with updates to Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.